130 studies found for:    "Arthritis, Juvenile Rheumatoid"
Show Display Options
Rank Status Study
1 Completed Ultrasonography in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis, Oligoarthritis;   Polyarticular Juvenile Rheumatoid Arthritis;   Systemic Juvenile Idiopathic Arthritis
Intervention: Device: Ultrasonography
2 Completed
Has Results
Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
Conditions: Juvenile Chronic Polyarthritis;   Juvenile Idiopathic Arthritis;   Juvenile Rheumatoid Arthritis
Interventions: Drug: methotrexate;   Drug: methotrexate - etanercept - prednisolone arm
3 Recruiting Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
Condition: Arthritis, Juvenile Rheumatoid
Intervention:
4 Unknown  Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Biological: Measles, Mumps, Rubella vaccination
5 Completed Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: meloxicam oral suspension;   Drug: naproxen oral suspension
6 Terminated Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease
Conditions: Arthritis, Juvenile Rheumatoid;   Crohn Disease
Intervention: Drug: somatropin [rDNA origin] for injection
7 Completed The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis
Conditions: Arthritis, Juvenile Rheumatoid;   Uveitis
Intervention: Drug: Chicken type II collagen
8 Recruiting Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Drug: Sulfasalazine
9 Completed A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: meloxicam 0.25 mg/kg;   Drug: meloxicam 0.125 mg/kg;   Drug: naproxen 10 mg/kg
10 Completed Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Drug: ACZ885
11 Terminated Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis
Conditions: Arthritis, Juvenile Rheumatoid;   Still's Disease, Juvenile Onset
Intervention: Biological: tocilizumab
12 Completed A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: Celecoxib;   Drug: Naproxen
13 Terminated
Has Results
Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: Celecoxib;   Drug: nsNSAIDs
14 Not yet recruiting Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Biological: Blood sample
15 Completed Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Intervention: Drug: Calcium carbonate
16 Completed BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Placebo
17 Completed A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: Celecoxib;   Drug: Naproxen
18 Terminated Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Intervention: Drug: Infliximab
19 Active, not recruiting Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults
Condition: Juvenile Idiopathic Arthritis
Intervention: Biological: Rilonacept
20 Active, not recruiting A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: CNTO 148 (Golimumab);   Drug: Placebo;   Drug: Methotrexate

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years